We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
93 hedge funds and large institutions have $387M invested in Iovance Biotherapeutics in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 6
50% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 24
13% more funds holding
Funds holding: 82 → 93 (+11)
8% more capital invested
Capital invested by funds: $357M → $387M (+$30M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
82% less call options, than puts
Call options by funds: $1.55M | Put options by funds: $8.43M
Holders
93
Holders Change
+11
Holders Change %
+13.41%
% of All Funds
2.48%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
18
Increased
36
Reduced
24
Closed
6
Calls
$1.55M
Puts
$8.43M
Net Calls
-$6.88M
Net Calls Change
+$1.65M
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$19.8M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
+$11.1M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$10.3M |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
+$5.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.43M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$10.2M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.5M |
| 3 |
Goldman Sachs
New York
|
-$1.78M |
| 4 |
Millennium Management
New York
|
-$1.25M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.02M |
